Experience:
No experience
Employment Type:
Full time
Posted:
10/2/2017
Job Category:
Transportation
Lead BIA Operations - Web Id: 29375
(This job is no longer available)
Bristol-Myers Squibb | Newark, NJ
loading
loading
School
Major
Grad Date
 
 

Not sure what types of jobs you are interested in?


Explore Jobs
Based on Your Education

Follow This Company
Share

Job Description

Reference # 9455 

Lead BIA Operations & GMS Analytics

Requires Master's (or foreign equivalent.) in Business Administrative, Engineering or related +7 years’ experience. Use Experience with Strategic Management Consulting, Analytics, Master Data Management, Data Quality; Core Software including SAS, Advanced Excel; Bus Transformation/Change Management; Engineering /Manufacturing experience to drive day-to-day operations & planning processes of Worldwide Analytics Organization inclusive of: R&D, Commercial, Corporate, HR & GMS. 25% of domestic & international travel required. Bristol-Myers Squibb Company. Lawrenceville, NJ. Full Time. 

 

Web Id: 29375


recblid g1vftf1e4tzkf0i6gwzb21c8rhlkoo

About Bristol-Myers Squibb

Bristol-Myers Squibb Company (BMS) is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceutical and nutritional products. The Company had two segments: Pharmaceuticals and Nutritionals. The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business. The Nutritionals segment consists of Mead Johnson Nutritionals (Mead Johnson), primarily an infant formula and children's nutritionals business. In June 2008, BMS acquired Kosan Biosciences, Inc., a developer of oncology products. In August 2008, the Company completed the divestiture of its ConvaTec business to Cidron Healthcare Limited, an affiliate of Nordic Capital Fund VII and Avista. In December 2008, BMS completed the sale of its brand business in Egypt to GlaxoSmithKline. In July 2009, the Company's branded generics business, which comprises a portfolio of 13 branded pharmaceuticals was acquired by GlaxoSmithKline plc.